Medicenna Therapeutics Corp. (TSX:MDNA)

Medicenna Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	5.69	6.25	24.84	16.98	33.6	20.54
Cash & Short-Term Investments	5.69	6.25	24.84	16.98	33.6	20.54
Cash Growth	-72.18%	-74.83%	46.26%	-49.45%	63.60%	-49.15%
Other Receivables	1.52	1.35	2.7	1.16	0.86	1.31
Receivables	1.52	1.35	2.7	1.16	0.86	1.31
Prepaid Expenses	0.92	0.72	0.64	0.93	1.93	1.55
Total Current Assets	8.13	8.32	28.17	19.08	36.39	23.39
Property, Plant & Equipment	0.08	0.09	0.16	-	-	-
Other Intangible Assets	0.05	0.05	0.05	0.06	0.06	0.07
Total Assets	8.25	8.45	28.38	19.13	36.45	23.46

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	6.12	4.85	2.7	2.07	1.62	1.67
Accrued Expenses	0.3	0.55	1.69	0.79	2.18	0.95
Current Portion of Leases	0.07	0.07	0.05	-	-	-
Other Current Liabilities	-	-	-	-	3.16	-
Total Current Liabilities	6.49	5.47	4.44	2.86	6.96	2.62
Long-Term Leases	0.03	0.05	0.12	-	-	-
Other Long-Term Liabilities	0.05	0.45	4.73	11.08	-	-
Total Liabilities	6.58	5.97	9.29	13.94	6.96	2.62

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	129.25	126.26	116.3	100.92	100.92	83.67
Additional Paid-In Capital	13.96	12.73	11.22	10.7	9.49	7.93
Retained Earnings	-141.74	-136.66	-118.25	-106.45	-80.98	-70.93
Comprehensive Income & Other	0.21	0.16	9.83	0.02	0.06	0.17
Shareholders' Equity	1.67	2.48	19.1	5.19	29.49	20.84
Total Liabilities & Equity	8.25	8.45	28.38	19.13	36.45	23.46

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	0.1	0.12	0.17	-	-	-
Net Cash (Debt)	5.59	6.13	24.67	16.98	33.6	20.54
Net Cash Growth	-72.47%	-75.14%	45.27%	-49.45%	63.60%	-49.11%
Net Cash Per Share	0.07	0.07	0.32	0.24	0.52	0.38
Filing Date Shares Outstanding	92.3	92.3	83.38	76.18	69.64	56.3
Total Common Shares Outstanding	92.3	83.42	78.22	69.64	69.64	55.65
Working Capital	1.64	2.85	23.74	16.21	29.43	20.77
Book Value Per Share	0.02	0.03	0.24	0.07	0.42	0.37
Tangible Book Value	1.63	2.44	19.04	5.13	29.43	20.77
Tangible Book Value Per Share	0.02	0.03	0.24	0.07	0.42	0.37

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error